𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of sirolimus and low-dose calcineurin inhibitor in lung transplant recipients with renal impairment: Results of a controlled pilot study

✍ Scribed by Shitrit, David; Rahamimov, Ruth; Gidon, Sahar; Bakal, Ilana; Bargil-Shitrit, Ariella; Milton, Saute; Kramer, Mordechai R.

Book ID
109067050
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
73 KB
Volume
67
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sirolimus in liver transplant recipients
Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens
✍ Derek DuBay; Rob J. Smith; Kenneth G. Qiu; Gary A. Levy; Leslie Lilly; George Th πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 129 KB

The purpose of this study is to review the clinical experience with sirolimus immunosuppression in liver transplant patients with calcineurin inhibitor-induced chronic renal insufficiency. The study design is a case-control retrospective series. Fifty-seven liver transplant patients with renal insuf

A randomized controlled trial of late co
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function
✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 307 KB πŸ‘ 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin